Albumin-Binding Peptide Analogs
Category of peptides described as engineered to bind serum albumin for a longer half-life; specific products are undefined in the literature.
Overview
Albumin binding is a genuine biopharmaceutical strategy in which peptide or protein drugs are modified, for example by fatty-acid acylation, so that they associate with serum albumin and circulate longer. This catalog entry groups peptides described as albumin-binding analogs, but no specific product or sequence is defined under these names in peer-reviewed sources.
The existence of half-life-extension chemistry in drug development does not validate the identity of these particular catalog items.